# Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome

> **NCT00584246** · PHASE4 · WITHDRAWN · sponsor: **University of South Florida**

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Pregabalin (Lyrica)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00584246
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped due to budget (personnel) limitations.
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584246, "Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00584246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*